News Fertility & pregnancy

Maven Clinic signs agreement to support Indian couples battling infertility

By Published On: October 17, 2022
Maven Clinic signs agreement to support Indian couples battling infertility

Maven Clinic has announced an agreement with Indian-based fertility company Indira IVF to help couples struggling to conceive.

Indira IVF, India’s largest fertility service provider, operates more than 100 centres across the country, helping over 100,000 couples become parents over the last decade.

The new partnership will extend Maven Clinic’s global position, helping the US company to deliver fertility care to its Indian members.

Maven members in India will have access to virtual family building care through the company’s platform, in addition to an added layer of local, in-person support, including clinical care and other benefits offered by Indira IVF.

The news comes at a time when the need for global family building care is at an all-time high.

According to a survey from Maven, while 32% of companies plan to expand their family building benefits over the next year, the process is more complex for companies with a global workforce that have to navigate local nuances in each country.

Having a benefits partner that understands these nuances and the needs of employees can help employers deliver locally-relevant family building care, the report has found.

Over the past year, Maven Clinic has increased the number of international members it supports as employers with a global workforce seek to provide equitable family building care to all employees.

Indira IVF marks the latest addition to the company’s global fertility clinic referral network, which is part of its Global Fertility and Family Building programme.

Maven members have access to “care advocates” who are trained to understand the members’ cultural and country-specific context, and can offer local guidance as they navigate any path to parenthood, including preconception, fertility treatments, fertility preservation, adoption or surrogacy.

 

Employers see increased demand for menopause support, says report
Bayer's contraceptive Mirena approved in Europe for extended duration